Latest filing published 09 Oct 2018 for ZEVRA THERAPEUTICS, INC., €5.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -74.9%Entry US$41.44 · Close at T+365 US$10.40
- -76.9%Entry US$72.80 · Close at T+365 US$16.80
- +27.6%Entry US$60.80 · Close at T+365 US$77.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Delaware Street Capital Master Fund, L.P.: trading record in brief
Delaware Street Capital Master Fund, L.P. is a declared insider of Zevra Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 13 September 2017 to 5 October 2018.
Purchases make up the whole of the open-market record (5 purchases, €7.1M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2018 to date brings 2 purchases and no sales.
A typical purchase (the median) is worth €511k. Of 5 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +1.3%. This is a record of the past, not a forecast.
The latest filing, published on 9 October 2018, reports an open-market purchase of €5.2M in Zevra Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Delaware Street Capital Master Fund, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000,000 shares@ US$3.0083.4% of flowCommon Stock, par value $0.0001SEC:0000899243-18-026415:0Canonical exit: 3 Jan 2019 (T+90)
- 304,283 shares@ US$4.0016.6% of flowCommon Stock, par value $0.0001SEC:0000899243-18-020957:0Canonical exit: 28 Oct 2018 (T+90)
- 186,831 shares@ US$3.2527.2% of flowCommon Stock, par value $0.0001SEC:0000899243-17-022122:0Canonical exit: 12 Dec 2017 (T+90)
- 200 shares@ US$3.250.0% of flowCommon Stock, par value $0.0001SEC:0000899243-17-022122:1Canonical exit: 12 Dec 2017 (T+90)
- 138,857 shares@ US$3.30275.4% of flowCommon Stock, par value $0.0001SEC:0000899243-17-022122:2Canonical exit: 13 Dec 2017 (T+90)
5 of 5 declarations